North Carolina Expands Newborn Screening Program to Include Two More Disorders
In a significant advancement for infant health, North Carolina has broadened its Newborn Screening Program to encompass two additional disorders: Infantile Krabbe Disease and Guanidinoacetate Methyltransferase (GAMT) Deficiency. This expansion coincides with the 60th anniversary of the program, celebrated this September during National Newborn Screening Awareness Month.
According to NC Health and Human Services Secretary Dev Sangvai, “North Carolina’s Newborn Screening Program has helped generations of families by ensuring babies receive timely, lifesaving testing in their first days of life.” He emphasized the importance of expanding the screening panel to enhance the health outcomes for children.
Newborn screening plays a vital role in detecting rare, severe, and treatable disorders early, often before symptoms manifest. Approximately 120,000 newborns arrive each year in North Carolina, and annually, screening identifies over 250 infants with various disorders, including metabolic, endocrine, and hemoglobin issues. Timely diagnosis and treatment can be crucial, potentially saving lives and improving the quality of life for affected families.
The process involves collecting a few drops of the newborn’s blood via heel-prick, which is then analyzed at the State Laboratory of Public Health for any serious health conditions. This early detection mechanism links infants to necessary follow-up services, ensuring a healthier start in life.
Dr. Scott Shone, State Lab Director at the NCDHHS Division of Public Health, highlighted the dedication of the team, stating, “Early detection saves lives, and newborn screening remains one of our most important tools for protecting infant health.” He praised the public health teams and partners for their unwavering commitment to providing reliable, high-quality testing.
The expansion of the newborn screening panel is part of an ongoing effort to improve public health services. With the inclusion of GAMT deficiency and Infantile Krabbe Disease, North Carolina has added seven new conditions to the screening panel over the past six years. GAMT deficiency affects the muscles, brain, and nervous system, while Infantile Krabbe Disease primarily impacts the nervous system. Both conditions can lead to severe health issues if untreated, but early intervention can significantly enhance health outcomes.
For more detailed information about the NCDHHS Newborn Screening Program, visit the State Laboratory of Public Health website. Additional resources can be found on the Child and Family Well-Being Division page, and more insights into the daily operations of the program are available on the Newborn Screening Laboratories page.
Read More Here
